Evidence map›Paper›PMID 30046336›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2018

Pharmacoacupuncture for Idiopathic Parkinson's Disease: A Systematic Review of Randomized Controlled Trials.

Ki-Ho Cho, Tae-Hun Kim, Woo-Sang Jung, Sang-Kwan Moon, Chang-Nam Ko, Seung-Yeon Cho, Chan-Yong Jeon, Tae Young Choi, Myeong Soo Lee, Sang-Ho Lee and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Screening for Sarcopenia (Physical Frailty) in the COVID-19 Era.International journal of endocrinology · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ki-Ho ChoDepartment of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Tae-Hun KimKorean Medicine Clinical Trial Center, Korean Medicine Hospital, Kyung Hee University, Seoul, Republic of Korea.ORCID 0000-0002-8448-3219
Woo-Sang JungDepartment of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Sang-Kwan MoonDepartment of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Chang-Nam KoDepartment of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Seung-Yeon ChoDepartment of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.ORCID 0000-0003-3149-9759
Chan-Yong JeonDepartment of Korean Internal Medicine, College of Korean Medicine, Gachon University, Seongnam, Republic of Korea.
Tae Young ChoiClinical Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID 0000-0003-0638-2153
Myeong Soo LeeClinical Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.ORCID 0000-0001-6651-7641
Sang-Ho LeeGangdong Mokhuri Oriental Medical Hospital, Department of Internal Medicine, Seoul, Republic of Korea.
Eun Kyoung ChungDivision of Clinical Pharmacy, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Seungwon KwonDepartment of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.ORCID 0000-0002-1857-3515
Kyung Hee University · KRKorea Institute of Oriental Medicine · KRGachon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPharmacoacupuncture is a new acupuncture treatment that stimulates acupuncture points by injecting herbal medicine into them. Recently, pharmacoacupuncture has been widely used in the treatment of idiopathic Parkinson's disease in traditional East Asian medicine. The purpose of this systematic review is to evaluate the efficacy and safety of pharmacoacupuncture in the treatment of idiopathic Parkinson's disease.

methodsThe following electronic databases were searched for studies published in or before December 2016: Medline, Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, OASIS, and CNKI, without language restriction. The main outcome assessed was the total Unified Parkinson's Disease Rating Scale (UPDRS) score. The details of the pharmacoacupuncture intervention, such as the herbal medicine and acupuncture points used, were also investigated.

resultsFrom 138 studies, 3 randomized controlled trials were included; the number of patients analyzed was 134. Most of the studies showed considerable methodological flaws. There was heterogeneity of the intervention type and treatment duration in the included studies. Therefore, we could not conduct a meta-analysis. In one study, adjunctive bee venom pharmacoacupuncture therapy significantly improved total UPDRS scores compared with conventional therapy alone. Another study, which used adjunctive Kakkonein pharmacoacupuncture, did not reveal significant improvement compared with conventional therapy alone. A third study reported that Mailuoning pharmacoacupuncture was able to significantly improve the modified Webster Symptom Score when compared with no treatment. Adverse events related to the pharmacoacupuncture were reported in only one case, itching caused by the bee venom.

conclusionsOur findings regarding the efficacy of pharmacoacupuncture as a therapy for idiopathic Parkinson's disease are currently inconclusive. Further large and rigorous clinical trials are needed.

Identifiers

PMID30046336
PMCPMC6036809
OpenAlexW2810942863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.